- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Evommune Inc (EVMN)
Evommune Inc stock price live, this page displays NYSE EVMN stock exchange data. View the EVMN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Evommune Inc real time stock price chart below.
What Is the Evommune Inc Stock Price Today?
The Evommune Inc stock price today is 17.91.
What Is the Stock Symbol for Evommune Inc?
The stock symbol for Evommune Inc is "EVMN."
What Stock Exchange Does Evommune Inc Trade On?
Evommune Inc is listed and trades on the NYSE stock exchange.
Is Evommune Inc a Good Stock to Buy?
Determining whether Evommune Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVMN quote. (ISIN: US30054Y1073)
What Is the Evommune Inc Stock Price Today?
The Evommune Inc stock price today is 17.91.
What Is the Stock Symbol for Evommune Inc?
The stock symbol for Evommune Inc is "EVMN."
What Stock Exchange Does Evommune Inc Trade On?
Evommune Inc is listed and trades on the NYSE stock exchange.
Is Evommune Inc a Good Stock to Buy?
Determining whether Evommune Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVMN quote. (ISIN: US30054Y1073)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.21
18.11
52 wk Range
13.89
24.03
EVMN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.2118.11
52 wk Range
13.8924.03
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EVMN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
39.33
Upside
+119.62%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Evommune Inc Company Profile
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products includes EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
Compare EVMN to Peers and Sector
Metrics to compare | EVMN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVMNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.0x | −3.2x | −0.6x | |
PEG Ratio | - | −0.05 | 0.00 | |
Price/Book | −3.1x | 1.7x | 2.6x | |
Price / LTM Sales | 43.4x | 209.5x | 3.2x | |
Upside (Analyst Target) | 133.8% | 221.9% | 41.8% | |
Fair Value Upside | Unlock | 5.0% | 5.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 39.33
(+119.62% Upside)
Earnings
Latest Release
Dec 11, 2025
EPS / Forecast
-8.07 / --
Revenue / Forecast
10.00M / --
People Also Watch
FAQ
What Is the Evommune (EVMN) Stock Price Today?
The Evommune stock price today is 17.91
What Stock Exchange Does Evommune Trade On?
Evommune is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Evommune?
The stock symbol for Evommune is "EVMN."
What Is the Evommune Market Cap?
As of today, Evommune market cap is 564.60M.
What Is Evommune's Earnings Per Share (TTM)?
The Evommune EPS (TTM) is -40.87.
When Is the Next Evommune Earnings Date?
Evommune will release its next earnings report on Feb 25, 2026.
From a Technical Analysis Perspective, Is EVMN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Evommune Stock Split?
Evommune has split 0 times.
How Many Employees Does Evommune Have?
Evommune has 45 employees.
What is the current trading status of Evommune (EVMN)?
As of Dec 24, 2025, Evommune (EVMN) is trading at a price of 17.91, with a previous close of 17.91. The stock has fluctuated within a day range of 17.21 to 18.11, while its 52-week range spans from 13.89 to 24.03.
What Is Evommune (EVMN) Price Target According to Analysts?
The average 12-month price target for Evommune is USD39.33333, with a high estimate of USD42 and a low estimate of USD36. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +119.62% Upside potential.
What Is the EVMN After Hours Price?
EVMN's last after hours stock price is 18.72, the stock has decreased by 0.81, or 4.52%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.